United States · FDA National Drug Code directory
Naproxen
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 43063-650_39f9273f-87db-b615-e063-6294a90a03b6
- Product NDC
- 43063-650
- Form
- TABLET
- Composition / generic term
- Naproxen
- Labeler
- PD-Rx Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20100218
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN — 375 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 6 TABLET in 1 BOTTLE, PLASTIC (43063-650-06) · 43063-650-06
- 10 TABLET in 1 BOTTLE, PLASTIC (43063-650-10) · 43063-650-10
- 14 TABLET in 1 BOTTLE, PLASTIC (43063-650-14) · 43063-650-14
- 15 TABLET in 1 BOTTLE, PLASTIC (43063-650-15) · 43063-650-15
- 20 TABLET in 1 BOTTLE, PLASTIC (43063-650-20) · 43063-650-20
- 21 TABLET in 1 BOTTLE, PLASTIC (43063-650-21) · 43063-650-21
- 24 TABLET in 1 BOTTLE, PLASTIC (43063-650-24) · 43063-650-24
- 30 TABLET in 1 BOTTLE, PLASTIC (43063-650-30) · 43063-650-30
- 42 TABLET in 1 BOTTLE, PLASTIC (43063-650-42) · 43063-650-42
- 60 TABLET in 1 BOTTLE, PLASTIC (43063-650-60) · 43063-650-60
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →